Using Cardiac MRI to Characterise the Dynamic Changes Which Occur in the Acutely Reperfused STEMI Patient
Launched by NATIONAL HEART CENTRE SINGAPORE · May 31, 2016
Trial Information
Current as of May 15, 2025
Unknown status
Keywords
ClinConnect Summary
This will be a prospective observational study with serial CMR imaging only.
CMR scan Each patient will receive one CMR scan performed on Day 1, Day 3, Day 5, Day 10 following the PPCI procedure on a 3T Philips scanner (see study flow below). All CMR scans will be analysed at a central CMR corelab.
For Day 1, 3, 5, 7 and 10 CMRs, parameters will be collected as follows:
* Left ventricle (LV) ejection fraction and indexed LV end systolic and diastolic volumes and mass using short-axis SSFP cine imaging and myocardial tagging sequences).
* The AAR by T1 and T2 mapping18 as a percentage of ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Confirmed STEMI as per PPCI procedure reports/ clinical notes
- • 2. Proximal to mid coronary artery occlusion.
- • 3. Ability to provide informed consent
- Exclusion Criteria:
- • 1. Previous myocardial infarction or coronary artery bypass graft surgery
- • 2. Contraindication for CMR (e.g. ferromagnetic implants, claustrophobia, estimated glomerular filtration rate \<30mL/min)
About National Heart Centre Singapore
The National Heart Centre Singapore (NHCS) is a leading institution dedicated to advancing cardiovascular care and research in Singapore and the Asia-Pacific region. As a premier clinical trial sponsor, NHCS is committed to improving heart health through innovative research and clinical excellence. The center specializes in a wide range of cardiovascular conditions, leveraging cutting-edge technology and a multidisciplinary approach to develop and evaluate new therapies. With a strong emphasis on patient-centered care, NHCS collaborates with various stakeholders to enhance clinical outcomes and contribute to the global body of cardiovascular knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
National Heart Centre Singapore
Principal Investigator
National Heart Centre Singapore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials